Cancer research at BESSY II: Binding Mechanisms of Therapeutic Substances Deciphered
The study is displayed on the cover of the journal Chemmedchem. © Chemmedchem/VCH Wiley
In tumor cells, the DNA is altered in comparison to normal body cells. How such changes can be prevented or inhibited is an exciting field of research with great relevance for the development of cancer treatments. An interdisciplinary team has now analysed the possible binding mechanisms in certain therapeutic substances from the tetrazole hydrazide group using protein crystallography at BESSY II.
Certain proteins such as human histone demethylases, including the KDM4 protein, play a role in the development of tumour cells. They bind to the DNA and modify it so that the cell can become cancerous. Therapeutic substances that are able to inhibit or even reverse such changes are of particular interest.
Biochemist Prof. Dr. Udo Heinemann from the Max Delbrück Centre in Berlin-Buch is investigating such processes. In cooperation with chemists led by Prof. Dr. Andreas Link from the University of Greifswald and the team led by Dr. Manfred Weiss at the HZB, he has now investigated how and where certain therapeutic substances from the tetrazole hydrazide group dock to these protein molecules and thus inhibit their harmful effect.
KDM4 protein crystals analysed
Link initially produced variations of tetrazole hydrazide substances. For structural analysis, crystals had to be grown from KDM4 proteins - a difficult task that Dr. Piotr Malecki and Manfred Weiss had taken on at the HZB. The KDM4 protein crystals were then soaked in a specific substance before being analyzed with strong X-rays on the MX beamlines of BESSY II. A refined analysis showed not only the three-dimensional architecture of the KDM4 protein, but also exactly where the active substances had docked to the KDM4 molecule.
"This class of substances has not yet been structurally investigated," explains Manfred Weiss. And Udo Heinemann from the MDC explains: "We will now evaluate where there are opportunities to dock even stronger within the 3D structure of the KDM4. Then we might also be able to develop drugs that inhibit the KDM4 even more and thus have the potential to become a therapeutic."
- Small powerhouses for very special lightAn international team presents the functional principle of a new source of synchrotron radiation in Nature Communications Physics. Steady-state microbunching (SSMB) allows to build efficient and powerful radiation sources for coherent UV radiation in the future. This is very attractive for applications in basic research as well in the semiconductor industry.
- New Method for Absorption Correction to Improve Dental FillingsA research team led by Dr. Ioanna Mantouvalou has developed a method to more accurately depict the elemental distributions in dental materials than previously possible. The used confocal micro-X-ray fluorescence (micro-XRF) analysis provides three-dimensional elemental images that contain distortions. These distortions occur when X-rays pass through materials of different densities and compositions. By utilizing micro-CT data, which provides detailed 3D images of the material structure, and chemical information from X-ray absorption spectroscopy (XAS) experiments conducted in the laboratory (BLiX, TU Berlin) and at the synchrotron light source BESSY II, the researchers have improved the method.
- Helmholtz Institute for Polymers in Energy Applications (HIPOLE Jena) InauguratedOn June 17, 2024, the Helmholtz Institute for Polymers in Energy Applications (HIPOLE Jena) was officially inaugurated in Jena in the presence of Wolfgang Tiefensee, Minister for Economy, Science, and Digital Society of the Free State of Thuringia. The institute was founded by the Helmholtz Center Berlin for Materials and Energy (HZB) in cooperation with the Friedrich Schiller University Jena. It is dedicated to developing sustainable polymer materials for energy technologies, which are expected to play a key role in the energy transition and support Germany’s goal of becoming climate-neutral by 2045.